We are live on ! Find out more
CABA icon

Cabaletta Bio

55 hedge funds and large institutions have $202M invested in Cabaletta Bio in 2020 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 17 increasing their positions, 18 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 5

18% more capital invested

Capital invested by funds: $171M → $202M (+$31M)

2% more funds holding

Funds holding: 5455 (+1)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0.81% less ownership

Funds ownership: 68.03%67.22% (-0.81%)

6% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 18

Holders
55
Holders Change
+1
Holders Change %
+1.85%
% of All Funds
0.97%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
6
Increased
17
Reduced
18
Closed
5
Calls
Puts
Net Calls
Net Calls Change

CABA Hedge Fund Activity: Q4 2020 in Review

55 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Cabaletta Bio (CABA) for Q4 2020, worth a combined $202M — up 18% from $171M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new CABA positions and 5 closed out — a net gain of 1 holder — while 17 added to existing stakes and 18 trimmed.

The largest buyer was BlackRock, adding an estimated $4.14M. The largest seller was 5AM Venture Management, cutting an estimated $3.87M.

  • 55 institutional investors held Cabaletta Bio (CABA) as of Q4 2020, up from 54 in Q3 2020.
  • Funds reported $202M of Cabaletta Bio stock for Q4 2020, up 18% quarter-over-quarter.
  • 6 funds opened new Cabaletta Bio positions in Q4 2020 and 5 closed out, a net change of +1 holder.
  • The largest Cabaletta Bio buyer in Q4 2020 was BlackRock, an estimated $4.14M added.
  • The largest Cabaletta Bio seller in Q4 2020 was 5AM Venture Management, an estimated $3.87M sold.

Based on aggregated 13F filings for Q4 2020.